head and neck cancer patients starting Chemo
Protocol: STUDY00004326
Full Title
The Impact of PEG Tube Placement and Speech Intervention on Nutritional Status, Functional Status, and Quality of Life in Patients with Head and Neck Cancer.
Description
This study enrolls adults diagnosed with head and neck cancer who have plans to complete chemoradiotherapy. The purpose of this study is to learn the best timing for feeding tube placement and speech therapy to create the best quality of life for patients.

You will be in this study for about 14-16 months. Before starting chemoradiation therapy, you will complete a barium swallow where you will drink a mix and have x-rays taken. During the study you will complete questionnaires. Study takes place at ECMC (462 Grider St. Buffalo, NY 14215).

Technical Description

To investigate the clinical outcomes of prophylactic versus reactive PEG tube placement combined with early speech therapy intervention in head and neck cancer patients undergoing concurrent chemo-radiation therapy.
Compensation: No
Eligibility
Adults ages 18+.
Patients with Head and Neck Cancer being treated at ECMC and Cancer Care WNY.
Patients planning to receive concurrent chemo-radiation therapy.
Age Group: Adults
Principal Investigator: Colleen Brady
Contact(s)
JAMES ZEMER
jameszem@buffalo.edu
+1 716-645-2521
Want to Learn More?
Let us know how the study team can reach you. If you do not hear back within 2 business days, reach out to the study team directly at the contact information above or email ctsiresearch@buffalo.edu and someone will assist you.